Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...
An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...
The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal ...
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...
Crossing legs during flights increases the risk of deep vein thrombosis (DVT), warns Dr. Neena Chandrasekaran. The cramped ...
Preparing to Initiate Clinical Development in Patients with Hematologic Malignancies in the First Quarter of 2025 Series B Financing Funds AUTX-703 Development through Phase 1 Clinical ...
Crossing your legs during air travel can increase the risk of developing deep vein thrombosis (DVT), warns Dr. Neena ...
Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...
Silence Therapeutics plc (NASDAQ:SLN), a biotechnology company specializing in RNA therapeutics, stands at a crucial juncture ...
Kura Oncology (KURA) and Kyowa Kirin announced topline results from KOMET-001, the Phase 2 registration-directed trial of ziftomenib, a highly ...
February is Black History Month.Here are some of Healio Women in Oncology’s recent stories that highlight the contributions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback